by Nathaniel Harding | Oct 18, 2022 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: New Blog: Ask a VC: How Can Startups Thrive in an Economic Downturn Builder Highlight: Oklahoma Biotech Innovation Cluster LP Highlight: Dr. Sam Dahr, MD Team Highlight: Intern Lauren...
by Nathaniel Harding | Sep 23, 2022 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: MoatBio Announces Successful Clinical Trials of Intranasal COVID-19 Vaccine Builder Highlight: OKC MED Week LP Highlight: Presbyterian Health Foundation Cortado’s Due Diligence Process...
by Nathaniel Harding | Sep 20, 2022 | Media
Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine OKLAHOMA CITY (Sept. 20, 2022) — Moat Biotechnology Corporation (MoatBio), a new...
by Nathaniel Harding | Aug 24, 2022 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: Cortado Ventures Starts Second Close at $40M for Fund II Builder Highlight: Oklahoma City Innovation District LP Highlight: The Farzaneh Family Team Highlight: Thank you Interns PortCo...
by Nathaniel Harding | Aug 15, 2022 | Uncategorized
OKLAHOMA CITY (Aug. 15, 2022) — Cortado Ventures announces it is starting the second close for its Fund II at $40 million. The Oklahoma City-based venture capital firm has already reached half of their $80 million Fund II goal in under 5 months, and has begun the...
